Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feedergoogle.co.in
Google Alert - dupilumab
Get the latest updates from Google Alert - dupilumab directly as they happen.
Follow now 108 followers
Latest posts
Last updated about 2 hours ago
Treatment of Allergic Bronchopulmonary Aspergillosis with Dupilumab Reduces IgE Levels ...
1 day ago
The mechanism of dupilumab offers a novel therapeutic approach to managing ABPA...
Tezepelumab and Dupilumab showed the largest improvements for nasal polyps - Reddit
about 8 hours ago
• Dupilumab: SNOT-22: roughly −17 to −21 Nasal polyp score: −1.7 to...
Where to find affordable Dupixent (dupilumab) medication or samples? - Facebook
about 7 hours ago
... (dupilumab) Injection 300 mg/2 mL(150 mg/mL) ForSubcutaneous Use Only 2 Pre-filled...
Dupilumab in Difficult-to-treat Chronic Spontaneous Urticaria: A Real-world Multicentre Cohort Study
about 7 hours ago
Chronic spontaneous urticaria (CSU) remains difficult to manage in patients refractory to...
Injection Pain Varies Widely Across Biologics for Atopic Dermatitis & Psoriasis
1 day ago
In addition, dupilumab autoinjectors were associated with higher pain compared with syringes...
Atopic Dermatitis Market to Expand Through 2030 Across the 7MM | DelveInsight
about 12 hours ago
• Dupixent (dupilumab): Regeneron Pharmaceuticals Dupixent is a fully-human monoclonal antibody that...
Infektionsrisiko unter JAK-Inhibitoren - medonline.at
about 6 hours ago
Zudem verweisen die Wissenschaftler darauf, dass Dupilumab bei Patienten mit atopischer Dermatitis...
Twelve-Month Effectiveness of Dupilumab on Eosinophilic Otitis Media in Patients ... - Sage Journals
1 day ago
Objective. To evaluate the 12-month effectiveness of dupilumab on subjective and objective...
In the phase 4 EVEREST trial, 64% of dupilumab-treated patients with severe CRSwNP and ...
about 17 hours ago
In the phase 4 EVEREST trial, 64% of dupilumab-treated patients with severe...
Unique Features of Nasal Airway and Airflow Improvement Post‐Dupilumab - PMC - NIH
about 12 hours ago
Dupilumab is a monoclonal antibody approved for treatment of chronic rhinosinusitis (CRS)...
The evaluation of cytokine profiles in atopic dermatitis patients treated with dupilumab - PMC
about 12 hours ago
Dupilumab is an effective treatment for moderate-to-severe atopic dermatitis (AD), yet a...
MRCPCH FOP Dupilumab Severe Asthma question: A 14-year-old with | iatroX
about 15 hours ago
Dupilumab Severe Asthma — MRCPCH FOP MCQ. Instant feedback + full explanation...